The U.S. Drug Enforcement Administration (DEA) on May 16, 2024, issued a proposed rule to move marijuana from its current classification as a Schedule I drug to a Schedule III drug, thereby loosening federal DEA restrictions.
The rescheduling of a controlled substance follows a formal rulemaking procedure that requires notice to the public, and an opportunity for comment and an administrative hearing. This proposal starts the process, where the Drug Enforcement Administration will gather and consider information and views submitted by the public, in order to make a determination about the appropriate schedule. During that process, and until a final rule is published, marijuana remains a schedule I controlled substance.
Under the CSA, Schedule I drugs have no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs include heroin, LSD and ecstasy. A Schedule I categorization means that not only is marijuana use (including sale, distribution and ingestion) illegal federally, but also that researchers face strict restrictions regarding access to the product, even for research purposes only. Moreover, businesses that manufacture, distribute or sell Schedule I drugs are unable to access the U.S. banking system, leaving business in the 38 states that have legalized marijuana unable to access safe banking.
WHY SHOULD YOU ATTEND?
The Marijuana legalization regulations have impacted Employers whether they are in a state where Marijuana has legalized medicinal and recreational usage. In addition to federal restrictions and state restrictions, many Employers do not know what leverage or power they have to manage the balance between legal Marijuana usage and managing a true drug-free workplace program, consider reasonable accommodations, and mitigate other federal regulations. This challenge impacts not only OSHA guidelines but it also impacts the American with Disabilities Act (ADA), Family Medical Leave Act (FMLA), and HIPPA Guidelines. Employers need guidance they can follow.
This training provides that guidance and will help Employers reduce their risk States have continued to join the Legalized Marijuana bandwagon but there are still different state regulations that are different from each other.
LEARNING OBJECTIVES
- How Can Employers mitigate Legalized Marijuana with their Drug-Free Workplace Program?
- How do the ADA, FMLA, and Legalized Marijuana overlap?
- What States and Local jurisdictions have Legalized Marijuana?
- What about the use of Medicinal Marijuana for chronic illnesses?
- What Reasonable Accommodations can be made by Employers when it comes to Marijuana in the workplace?
- What resources can Employers access to mitigate all the changes with Legalized Marijuana?
- What are the Federal regulations on the use of Marijuana in the workplace
- What states are restricting pre-employment drug testing for Marijuana?
- What are the types of Marijuana and how they are ingested?
- Does your Company have a true Drug Free Workplace Program?
- Learn if you are compliant with the Workers Comp requirements of a Drug-Free Program or lose the 4-5% discount;
- How will Employers mitigate drug-free workplaces with the new regulations?
- What policies should be in place to comply with the new regulation?
- What issues will HR professionals have to manage with the new regulations?
- Is Marijuana a reasonable accommodation
WHO WILL BENEFIT?
- All Employers
- Business Owners
- Company Leadership
- Compliance professionals
- HR Professionals
- Managers/Supervisors
- Employers in all industries
- Small Business Owners
The Marijuana legalization regulations have impacted Employers whether they are in a state where Marijuana has legalized medicinal and recreational usage. In addition to federal restrictions and state restrictions, many Employers do not know what leverage or power they have to manage the balance between legal Marijuana usage and managing a true drug-free workplace program, consider reasonable accommodations, and mitigate other federal regulations. This challenge impacts not only OSHA guidelines but it also impacts the American with Disabilities Act (ADA), Family Medical Leave Act (FMLA), and HIPPA Guidelines. Employers need guidance they can follow.
This training provides that guidance and will help Employers reduce their risk States have continued to join the Legalized Marijuana bandwagon but there are still different state regulations that are different from each other.
- How Can Employers mitigate Legalized Marijuana with their Drug-Free Workplace Program?
- How do the ADA, FMLA, and Legalized Marijuana overlap?
- What States and Local jurisdictions have Legalized Marijuana?
- What about the use of Medicinal Marijuana for chronic illnesses?
- What Reasonable Accommodations can be made by Employers when it comes to Marijuana in the workplace?
- What resources can Employers access to mitigate all the changes with Legalized Marijuana?
- What are the Federal regulations on the use of Marijuana in the workplace
- What states are restricting pre-employment drug testing for Marijuana?
- What are the types of Marijuana and how they are ingested?
- Does your Company have a true Drug Free Workplace Program?
- Learn if you are compliant with the Workers Comp requirements of a Drug-Free Program or lose the 4-5% discount;
- How will Employers mitigate drug-free workplaces with the new regulations?
- What policies should be in place to comply with the new regulation?
- What issues will HR professionals have to manage with the new regulations?
- Is Marijuana a reasonable accommodation
- All Employers
- Business Owners
- Company Leadership
- Compliance professionals
- HR Professionals
- Managers/Supervisors
- Employers in all industries
- Small Business Owners
Speaker Profile
![ins_img](/Speaker_Pics/Margie-Faulk-150x150.jpg)
Margie Faulk is a senior level human resources professional with over 15 years of HR management and compliance experience. A current Compliance Advisor for HR Compliance Solutions, LLC, Margie, has worked as an HR Compliance advisor for major corporations and small businesses in the small, large, private, public and Non-profit sectors. Margie has provided small to large businesses with risk management strategies that protect companies and reduces potential workplace fines and penalties from violation of employment regulations. Margie is bilingual (Spanish) fluent and Bi-cultural.Margie’s area of expertise includes Criminal Background Screening Policies and auditing, I-9 document correction and storage compliance, …
Upcoming Webinars
![](https://247compliance.com/Speaker_Pics/qalification.jpg)
Effective Onboarding: How to Welcome, Engage, and Retain Ne…
![](/static/images/default-webinar-info.jpg)
6-Hour Virtual Seminar on Learning the Highlights of Excel …
![](https://247compliance.com/Speaker_Pics/laboratory-3827743_960_720.jpg)
Impact Assessments For Supplier Change Notices
![](/static/images/default-webinar-info.jpg)
Developing an FDA/ISO Compliant Quality Management System
![](/static/images/default-webinar-info.jpg)
Aligning Your HR Strategy with Your Business Strategy
![](https://247compliance.com/Speaker_Pics/vda.jpg)
Accounting For Non Accountants : Debit, Credits And Financi…
![](/static/images/default-webinar-info.jpg)
I-9 Audits: Strengthening Your Immigration Compliance Strat…
![](/static/images/default-webinar-info.jpg)
Managing Difficult Employee Conversations
![](https://247compliance.com/static/images/travel-expenses.webp)
Dealing With Difficult People In Life & Work
![](/static/images/default-webinar-info.jpg)
Predictive Accounting: Driver-Based Budgeting And Rolling F…
![](/static/images/default-webinar-info.jpg)
Pay Equity Changes for 2024! What Employers Need to Know to…
![](/static/images/default-webinar-info.jpg)
Leader Branding: How to Communicate with Confidence to Attr…
![](/static/images/default-webinar-info.jpg)
![](/static/images/default-webinar-info.jpg)
Data Integrity and Privacy: Compliance with 21 CFR Part 11,…
![](/static/images/default-webinar-info.jpg)
Project Management for Non-Project Managers - How to commun…
![](https://247compliance.com/Speaker_Pics/currency-3118767_960_720.jpg)
Why EBITDA Doesn't Spell Cash Flow and What Does
![](/static/images/default-webinar-info.jpg)
Design Verification, Validation and Testing for Medical Dev…
![](https://247compliance.com/Speaker_Pics/oo.jpg)
FFIEC BSA/AML Examination Manual: What Compliance Officers …
![](https://247compliance.com/Speaker_Pics/ver.jpg )
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
![](/static/images/default-webinar-info.jpg)
Employee or Independent Contractor – U.S DOL Announces 2024…
![](https://247compliance.com/static/images/73.jpg)
![](https://247compliance.com/Speaker_Pics/download.jpg)
Human Factors Usability Studies Following ISO 62366 and FDA…
![](/static/images/default-webinar-info.jpg)
Best Practices in Complaint Management for Regulatory Compl…
![](/static/images/default-webinar-info.jpg)
Ensuring Safe and Effective Pharmaceutical Products: A Comp…
![](https://247compliance.com/Speaker_Pics/laboratory-3827743_960_720.jpg)
![](/static/images/default-webinar-info.jpg)
Embracing Diversity and Inclusion in Talent Acquisition
![](https://247compliance.com/Speaker_Pics/files.jpg)
Form W-9 Compliance to Avoid Penalties: TIN Verification, B…
![](/static/images/default-webinar-info.jpg)
![](/static/images/default-webinar-info.jpg)
Tattoos, hijabs, piercings, and pink hair: The challenges …
![](/static/images/default-webinar-info.jpg)
Gossip-Free: Leadership Techniques to Quell Office Chatter
![](/static/images/default-webinar-info.jpg)
Updated Metro 2®, e-OSCAR and the New Tougher FCRA/CFPB Com…
![](https://247compliance.com/Speaker_Pics/tax-blog1.png)
Understanding and Analyzing Financial Statements
![](/static/images/default-webinar-info.jpg)
Divorce, Adoption and Other Special Tax Topics
![](/static/images/default-webinar-info.jpg)
Design History File (DHF), the Device Master Record (DMR) a…
![](/static/images/default-webinar-info.jpg)
Is Your Culture Working For or Against Your Success? If You…
![](https://247compliance.com/static/images/sick.jpg)
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
![](/static/images/default-webinar-info.jpg)
Setting up Quality System for FDA Regulated Products: Tips …
![](/static/images/default-webinar-info.jpg)
![](/static/images/default-webinar-info.jpg)
Marketing to Medicare or Medicaid Beneficiaries - What You …
![](/static/images/default-webinar-info.jpg)
The Five Cs Of Commercial Credit: The Basic Elements Of Cre…
![](/static/images/default-webinar-info.jpg)
![](https://247compliance.com/static/images/pharma-trend.jpg)
Sunshine Act Reporting - Clarification for Clinical Research
![](/static/images/default-webinar-info.jpg)
Documenting Misconduct that Will Stand Up in Court
![](https://247compliance.com/Speaker_Pics/student-849821__340.jpg)
![](/static/images/default-webinar-info.jpg)
Stress, Change And Team Resilience Through Humor: An Intera…
![](https://247compliance.com/static/images/hr-employee.jpg)
Managing Toxic & Other Employees Who have Attitude Issues
![](https://247compliance.com/static/images/fda-ai.jpg)
FDA Regulation of Artificial Intelligence/ Machine Learning
![](/static/images/default-webinar-info.jpg)
Pharma 4.0: Next Generation Technology Approach to GxP Prod…
![](/static/images/default-webinar-info.jpg)
Excel - Lists and Tables - A Beginner's Guide to Managing L…
![](/static/images/default-webinar-info.jpg)
Patient Gifts, Discounts and Freebies: What You Can and Can…